Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants

, /PRNewswire/ — Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company developing proprietary water-soluble…